Advertisement

PharmacoEconomics

, Volume 5, Issue 1, pp 5–7 | Cite as

Dispensing by Physicians and Pharmacists

A UK Perspective
  • Tony Morton-Jones
  • Mike Pringle
Guest Editomal

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dyer C. Strict product liability arrives; implications for doctors. British Medical Journal 296: 635, 1988PubMedCrossRefGoogle Scholar
  2. Jennings SJ. Product liability and GPs. British Medical Journal 296: 936, 1988CrossRefGoogle Scholar
  3. Morton-Jones AJ, Pringle MAL. Prescribing costs in dispensing practices. British Medical Journal 303: 1244–1246, 1993CrossRefGoogle Scholar
  4. Nuffield Foundation Committee of Inquiry (chairman Clucas K) Pharmacy. Report. London, Nuffield Foundation, 1986Google Scholar
  5. Prescription Pricing Authority. Annual Report 1 April 1990–31 March 1991, p. 8, Newcastle, Prescription Pricing Authority, 1991Google Scholar
  6. Ryan M, Bond C. Dispensing physicians and prescribing pharmacists: economic considerations for the UK. PharmacoEconomics 5: 8–17, 1994PubMedCrossRefGoogle Scholar
  7. Tapster JV. Changing role of the community pharmacist. The Practitioner 231: 1370–4, 1987PubMedGoogle Scholar

Copyright information

© Adis International Limited 1994

Authors and Affiliations

  • Tony Morton-Jones
    • 1
  • Mike Pringle
    • 1
  1. 1.Department of General PracticeMedical School, Queen’s Medical CentreNottinghamUK

Personalised recommendations